• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Potential for Increasing Risk of Consent Refusal in COVID-19 Trials: Considering Underlying Reasons and Responses.

作者信息

Russell James A, Walley Keith R, Kalil Andre C, Fowler Robert

机构信息

Centre for Heart Lung Innovation and.

Division of Critical Care Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.

出版信息

Ann Am Thorac Soc. 2022 Sep;19(9):1446-1447. doi: 10.1513/AnnalsATS.202203-250VP.

DOI:10.1513/AnnalsATS.202203-250VP
PMID:35486858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9447399/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b11/9447399/e512720947a9/AnnalsATS.202203-250VPUf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b11/9447399/e512720947a9/AnnalsATS.202203-250VPUf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b11/9447399/e512720947a9/AnnalsATS.202203-250VPUf1.jpg

相似文献

1
The Potential for Increasing Risk of Consent Refusal in COVID-19 Trials: Considering Underlying Reasons and Responses.新冠病毒疾病试验中同意拒绝风险增加的可能性：探究潜在原因及应对措施
Ann Am Thorac Soc. 2022 Sep;19(9):1446-1447. doi: 10.1513/AnnalsATS.202203-250VP.
2
Assessment of Length and Readability of Informed Consent Documents for COVID-19 Vaccine Trials.新型冠状病毒肺炎疫苗试验知情同意书的长度与可读性评估
JAMA Netw Open. 2021 Apr 1;4(4):e2110843. doi: 10.1001/jamanetworkopen.2021.10843.
3
Informed versus randomised consent to clinical trials.临床试验中的知情同意与随机同意
Lancet. 1995 Oct 21;346(8982):1060-4. doi: 10.1016/s0140-6736(95)91741-1.
4
Rethinking Consent for Stroke Trials in Time-Sensitive Situations: Insights From the COVID-19 Pandemic.重新思考时间敏感情况下的中风试验中的同意问题：COVID-19 大流行带来的启示。
Stroke. 2021 Apr;52(4):1527-1531. doi: 10.1161/STROKEAHA.120.031976. Epub 2021 Feb 16.
5
Refusal rates and waivers of informed consent in pragmatic and comparative effectiveness RCTs: A systematic review.实用主义和对照疗效 RCT 中知情同意书的拒绝率和豁免：系统评价。
Contemp Clin Trials. 2021 May;104:106361. doi: 10.1016/j.cct.2021.106361. Epub 2021 Mar 15.
6
Informed consent and informed refusal.知情同意与知情拒绝。
Dermatol Surg. 1995 Jun;21(6):555-9. doi: 10.1111/j.1524-4725.1995.tb00261.x.
7
Informed consent during Covid-19.新冠疫情期间的知情同意
Natl Med J India. 2021 Mar-Apr;34(2):123-124. doi: 10.4103/0970-258X.326762.
8
Informed surgical consent during the COVID-19 pandemic: Exploring the risk of unknown-Update of informed consent form.2019年冠状病毒病大流行期间的知情手术同意书：探索未知风险——知情同意书的更新
J Surg Oncol. 2020 Nov;122(6):1259. doi: 10.1002/jso.26148. Epub 2020 Aug 12.
9
Professionally responsible coronavirus disease 2019 vaccination counseling of obstetrical and gynecologic patients.为妇产科患者提供专业的 2019 冠状病毒病疫苗接种咨询。
Am J Obstet Gynecol. 2021 May;224(5):470-478. doi: 10.1016/j.ajog.2021.01.027. Epub 2021 Feb 1.
10
Willingness to Donate Remnant Human Biospecimens in the Context of the COVID-19 Pandemic.在新冠疫情背景下捐赠剩余人类生物样本的意愿
Biopreserv Biobank. 2022 Apr;20(2):123-131. doi: 10.1089/bio.2021.0036. Epub 2021 Jul 16.

引用本文的文献

1
Examining Health Insurance and Non-Medical Challenges Among Vietnamese Americans in Texas During the COVID-19 Pandemic.审视新冠疫情期间德克萨斯州越南裔美国人的健康保险及非医疗挑战
Int J Environ Res Public Health. 2025 Jan 29;22(2):189. doi: 10.3390/ijerph22020189.
2
Informed consent and risk communication challenges in antimicrobial clinical trials: a scoping review.知情同意和风险沟通在抗菌药物临床试验中的挑战：范围综述。
BMJ Open. 2024 Nov 24;14(11):e082096. doi: 10.1136/bmjopen-2023-082096.
3
Protocol implementation during the COVID-19 pandemic: experiences from a randomized trial of stress ulcer prophylaxis.

本文引用的文献

1
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.干扰素 β-1a 联合瑞德西韦与单用瑞德西韦治疗住院 COVID-19 成人患者的疗效比较：一项双盲、随机、安慰剂对照、3 期临床试验。
Lancet Respir Med. 2021 Dec;9(12):1365-1376. doi: 10.1016/S2213-2600(21)00384-2. Epub 2021 Oct 18.
2
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.mRNA-1273 新型冠状病毒疫苗在盲法阶段完成时的效力。
N Engl J Med. 2021 Nov 4;385(19):1774-1785. doi: 10.1056/NEJMoa2113017. Epub 2021 Sep 22.
3
COVID-19 大流行期间的方案实施：一项应激性溃疡预防随机试验的经验。
BMC Med Res Methodol. 2024 May 4;24(1):109. doi: 10.1186/s12874-024-02233-2.
4
Trend in Clinical Trial Participation During COVID-19: A Secondary Analysis of the I-SPY COVID Clinical Trial.COVID-19 期间临床试验参与趋势：I-SPY COVID 临床试验的二次分析
Crit Care Explor. 2023 Jun 19;5(6):e0930. doi: 10.1097/CCE.0000000000000930. eCollection 2023 Jun.
5
Network Analysis for Uncovering the Relationship between Host Response and Clinical Factors to Virus Pathogen: Lessons from SARS-CoV-2.基于宿主反应和临床因素的病毒病原体关系的网络分析：来自 SARS-CoV-2 的经验。
Viruses. 2022 Oct 31;14(11):2422. doi: 10.3390/v14112422.
Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021).
德国新冠肺炎住院患者国家治疗指南要点总结：德国一份采用证据到决策框架的现行国家指南中的关键药理学建议（最后更新于2021年5月17日）
Infection. 2022 Feb;50(1):93-106. doi: 10.1007/s15010-021-01645-2. Epub 2021 Jul 6.
4
Covid-19 vaccine acceptance, hesitancy, and refusal among Canadian healthcare workers: A multicenter survey.加拿大医护人员对 COVID-19 疫苗的接受、犹豫和拒绝情况：一项多中心调查。
Am J Infect Control. 2021 Sep;49(9):1152-1157. doi: 10.1016/j.ajic.2021.04.079. Epub 2021 Apr 28.
5
Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study.新冠病毒感染后综合征低危人群的多器官损害：一项前瞻性、基于社区的研究。
BMJ Open. 2021 Mar 30;11(3):e048391. doi: 10.1136/bmjopen-2020-048391.
6
COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population.COVID-19 疫苗犹豫和抵制：澳大利亚全国代表性纵向调查中的相关因素。
PLoS One. 2021 Mar 24;16(3):e0248892. doi: 10.1371/journal.pone.0248892. eCollection 2021.
7
International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples.国际上对 COVID-19 疫苗接种意愿和拒绝率的估计：基于大样本的全国代表性快速系统评价和荟萃分析。
Vaccine. 2021 Apr 8;39(15):2024-2034. doi: 10.1016/j.vaccine.2021.02.005. Epub 2021 Feb 6.
8
Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom.爱尔兰和英国与新冠疫苗犹豫及抵触相关的心理特征。
Nat Commun. 2021 Jan 4;12(1):29. doi: 10.1038/s41467-020-20226-9.
9
Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease.向疫苗试验对象告知 COVID-19 疫苗加重临床疾病的风险。
Int J Clin Pract. 2021 Mar;75(3):e13795. doi: 10.1111/ijcp.13795. Epub 2020 Dec 4.
10
Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic.法国大流行期间，参与 COVID-19 疫苗临床试验的意愿和接种 COVID-19 疫苗的意愿。
Vaccine. 2020 Oct 21;38(45):7002-7006. doi: 10.1016/j.vaccine.2020.09.041. Epub 2020 Sep 17.